Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4225)
All Articles published online
|
Apr 28, 2005 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Sun WH, Ou XL, Cao DZ, Yu Q, Yu T, Hu JM, Zhu F, Sun YL, Fu XL, Su H. Efficacy of omeprazole and amoxicillin with either clarithromycin or metronidazole on eradication of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i16/2477.htm |
| Number | Citing Articles |
| 1 |
Ignasi Puig, Mireia Baylina, Jordi Sánchez-Delgado, Sheila López-Gongora, David Suarez, Pilar García-Iglesias, Neus Muñoz, Javier P. Gisbert, Cristina Dacoll, Henry Cohen, Xavier Calvet. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole forHelicobacter pylorifirst-line treatment. Journal of Antimicrobial Chemotherapy 2016; 71(10): 2740 doi: 10.1093/jac/dkw220
|
| 2 |
Guilherme A. Soares, Deivid W. Pires, Leonardo A. Pinto, Gustavo S. Rodrigues, André G. Prospero, Gabriel G. A. Biasotti, Gabriela N. Bittencourt, Erick G. Stoppa, Luciana A. Corá, Ricardo B. Oliveira, José R. A. Miranda. The Influence of Omeprazole on the Dissolution Processes of pH-Dependent Magnetic Tablets Assessed by Pharmacomagnetography. Pharmaceutics 2021; 13(8): 1274 doi: 10.3390/pharmaceutics13081274
|
| 3 |
René Robert, Valérie Gissot, Marc Pierrot, Leila Laksiri, Emmanuelle Mercier, Gwenael Prat, Daniel Villers, Jean-François Vincent, Michel Hira, Philippe Vignon, Patrick Charlot, Christophe Burucoa.
Helicobacter pylori infection is not associated with an increased hemorrhagic risk in patients in the intensive care unit. Critical Care 2006; 10(3) doi: 10.1186/cc4920
|
| 4 |
Endalew Gebeyehu, Desalegn Nigatu, Ephrem Engidawork, Yan Li. Self-reported adverse drug effects and associated factors among H. pylori infected patients on standard triple therapy: Prospective follow up study. PLOS ONE 2019; 14(11): e0225585 doi: 10.1371/journal.pone.0225585
|
| 5 |
J. Sánchez‐Delgado, P. García‐Iglesias, M. Castro‐Fernández, F. Bory, M. Barenys, L. Bujanda, J. Lisozain, M. M. Calvo, S. Torra, J. P. Gisbert, X. Calvet. High‐dose, ten‐day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates. Alimentary Pharmacology & Therapeutics 2012; 36(2): 190 doi: 10.1111/j.1365-2036.2012.05137.x
|
| 6 |
Bo Li, Xiaoqian Lan, Li Wang, Jiani Zhao, Jingli Ding, Hao Ding, Jun Lei, Yiping Wei, Wenxiong Zhang. Proton-pump inhibitor and amoxicillin-based triple therapy containing clarithromycin versus metronidazole for Helicobacter pylori: A meta-analysis. Microbial Pathogenesis 2020; 142: 104075 doi: 10.1016/j.micpath.2020.104075
|
| 7 |
Anti-ulcer activity of NS-EA 51 – A fraction of Nigella sativa seed, in histamine plus pylorus-ligated and hypothermia plus restrain stressed rat models. Journal of Pharmacy Research 2013; 6(1): 16 doi: 10.1016/j.jopr.2012.11.007
|
| 8 |
Mohammad Reza Esmaeili-Dooki, Hossein Shirdel, Mahmood Hajiahmadi. Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin. Iranian Journal of Pediatrics 2015; 25(6) doi: 10.5812/ijp.2360
|
| 9 |
Endalew Gebeyehu, Desalegn Nigatu, Ephrem Engidawork, Yan Li. Helicobacter pylori eradication rate of standard triple therapy and factors affecting eradication rate at Bahir Dar city administration, Northwest Ethiopia: A prospective follow up study. PLOS ONE 2019; 14(6): e0217645 doi: 10.1371/journal.pone.0217645
|
| 10 |
Naoki Chiba. Evidence‐Based Gastroenterology and Hepatology. 2010; : 102 doi: 10.1002/9781444314403.ch6
|
| 11 |
Masaki Murata, Mitsushige Sugimoto, Hitomi Mizuno, Takeshi Kanno, Kiichi Satoh. Clarithromycin Versus Metronidazole in First-Line Helicobacter Pylori Triple Eradication Therapy Based on Resistance to Antimicrobial Agents: Meta-Analysis. Journal of Clinical Medicine 2020; 9(2): 543 doi: 10.3390/jcm9020543
|
| 12 |
M. F. Zaater, Y. R. Tahboub, E. Ghanem. Determination and Stability Assessment of Clarithromycin in Human Plasma using RP-LC with Electrochemical Detection. Journal of Chromatographic Science 2012; doi: 10.1093/chromsci/bms055
|
| 13 |
Ben Wang, Zhi-Fa Lv, You-Hua Wang, Hui Wang, Xiao-Qun Liu, Yong Xie, Xiao-Jiang Zhou. Standard triple therapy for <italic>Helicobacter pylori</italic> infection in China: A meta-analysis. World Journal of Gastroenterology 2014; 20(40): 14973-14985 doi: 10.3748/wjg.v20.i40.14973
|
| 14 |
Ji Hyuk Kang, Yun Jeong Lim. Trend for Treatment ofHelicobacter pyloriin Overseas Country. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2012; 12(4): 224 doi: 10.7704/kjhugr.2012.12.4.224
|